Drug Trial Radar · NCT00006157
Treatment of Functional Bowel Disorders
Last checked: Nov 20, 2026Latest source record: Jan 13, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Jul 1996
Primary completion
Not stated
Study completion Mar 2001
Sponsor
- Sponsor type
- NIH
- First posted
- Aug 9, 2000
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose for this study is to compare clinical treatments for patients with functional bowel disorders (irritable bowel syndrome, abdominal pain, painful constipation) in women. We also plan to: 1) determine what clinical features (medical or psychological) determine which patients will improve to these treatments, and 2) understand if there are any physiological features that relate to improvement in symptoms and response to the treatments. We will compare a psychological treatment (cognitive-behavioral therapy - CBT) with education/attention placebo, and an antidepressant drug (desipramine) with a pill placebo. This is the first large-scale study designed to determine the therapeutic effects of these methods, and to also determine interactions among physiologic measures, psychologic and sociodemographic factors, severity of symptoms, and therapeutic improvement including quality of life.
Conditions
- Irritable Bowel Syndrome
- Constipation
- Abdominal Pain
- Functional Colonic Diseases
Interventions
DesipramineDrug
Cognitive Behavioral TreatmentBehavioral
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
UNC Center for Functional GI Motility Disorders
Chapel Hill, North Carolina
Centre for Addiction and Mental Health, Clark Site
Toronto, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.